- Home
- OCEAW vs SWIM Comparison
OCEAW vs SWIM Comparison
Compare OCEAW & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- SWIM
- Stock Information
- Founded
- OCEAW N/A
- SWIM 1956
- Country
- OCEAW United States
- SWIM United States
- Employees
- OCEAW 7
- SWIM N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- SWIM Plastic Products
- Sector
- OCEAW Health Care
- SWIM Industrials
- Exchange
- OCEAW Nasdaq
- SWIM Nasdaq
- Market Cap
- OCEAW N/A
- SWIM N/A
- IPO Year
- OCEAW 2021
- SWIM 2021
- Fundamental
- Price
- OCEAW $0.03
- SWIM $6.67
- Analyst Decision
- OCEAW
- SWIM Hold
- Analyst Count
- OCEAW 0
- SWIM 4
- Target Price
- OCEAW N/A
- SWIM $6.83
- AVG Volume (30 Days)
- OCEAW N/A
- SWIM 769.6K
- Earning Date
- OCEAW N/A
- SWIM 03-04-2025
- Dividend Yield
- OCEAW N/A
- SWIM N/A
- EPS Growth
- OCEAW N/A
- SWIM N/A
- EPS
- OCEAW N/A
- SWIM N/A
- Revenue
- OCEAW N/A
- SWIM $508,520,000.00
- Revenue This Year
- OCEAW N/A
- SWIM $6.10
- Revenue Next Year
- OCEAW N/A
- SWIM $5.44
- P/E Ratio
- OCEAW N/A
- SWIM N/A
- Revenue Growth
- OCEAW N/A
- SWIM N/A
- 52 Week Low
- OCEAW N/A
- SWIM $2.38
- 52 Week High
- OCEAW N/A
- SWIM $8.41
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- SWIM 49.63
- Support Level
- OCEAW N/A
- SWIM $6.19
- Resistance Level
- OCEAW N/A
- SWIM $7.25
- Average True Range (ATR)
- OCEAW 0.00
- SWIM 0.39
- MACD
- OCEAW 0.00
- SWIM -0.02
- Stochastic Oscillator
- OCEAW 0.00
- SWIM 51.13
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.